Orchid Completes Acquisition of Cam Bioceramics Coating Facility in China

Orchid Orthopedic Solutions completed its acquisition of Cam Bioceramics' coating facility and operations in China on December 15, 2015. Cam China provides hydroxylapatite plasma coating services and broadens Orchid's coating capabilities to comprise the U.S., Europe and Asia.

Source: Orchid Orthopedic Solutions

 

In response to merger and acquisition activity among OEMs, and to stay competitive in the orthopaedic industry, suppliers engage in M&A activity to expand capabilities and production, serving OEMs that may be seeking fewer suppliers, and like Orchid, broadening their geographic reach.

Thirteen M&A transactions occured among suppliers during 2015 thus far, an increase from 12 in 2014. Industry experts and top level executives expect further consolidation at the supplier level, among both the bigger contract manufacturers and the thousands of smaller ones that will seek a bigger partner to maintain viability moving forward.

Six induustry participants convened to share their observations on supplier M&A in ORTHOKNOW®, "Suppliers Consolidate in Response to OEM M&A Activity."